Nishadil
Signup Signin
Delhi | 25°C (windy)
Goldman Sachs Unveils Exclusive List of 48 Companies Primed for Acquisition Across Key Sectors

Goldman Sachs Unveils Exclusive List of 48 Companies Primed for Acquisition Across Key Sectors
Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target

Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target
Summit Therapeutics Soars: Cancer Drug Ivonesimab Delivers Breakthrough Survival Gains, Igniting Retail Investor Frenzy

Summit Therapeutics Soars: Cancer Drug Ivonesimab Delivers Breakthrough Survival Gains, Igniting Retail Investor Frenzy
Unlocking Potential: Top 5 Biotech Stocks Riding a Wave of Momentum

Unlocking Potential: Top 5 Biotech Stocks Riding a Wave of Momentum
Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.

Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.
Load more..